Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I don't know what clinical setting you are referring to. Once abt has the trest in the form they intend to market is to submit it to fda for approval. This a medical device not a drug. "Clinical trials" are not required.
I believed that the work with abt was complete and works. This can't be true or abt would be scambling to get the test on the market.
From the pictures and articles on the "point of care" test I thought this work was complete. Again, this can't be true or we would be hearing about.
We do know:
1. No new license agreement
2. No progress payment by abt
One other point, as you all know, these tests do not require the extensive testing required of drugs. There are no potential side effects. These tests work or don't work. There is no evaluation of side affects required as nothing is introduced into the body.
Maybe all of this will change soon.
It depends on the news, I hope a lot but I don't have a clue.
I doubt anything said on this board affects the price. Someone on this board selling large numbers of shares does have an effect. I got in this stock a number of years ago @ 20 cents, hence the 20c. I got out when it was falling from the $4.50 range. I got out at $2.65. I have made money and lost money in this stock. At present my cost is $.98. I sold a number of shares beginning in Sept. My average sale price was 0.67. The last shares I sold was in early Nov. I still have a large number of shares and hope bocx is successful. I'm glad you are still out there. I enjoy your posts. As for my pr release, I was just stirring the pot.
Made up. I am waiting for Mysscat to tell me what a jerk I am.
How's this for news?
1. No new licensee in the near (or distant) future.
2. Expect abt to return it's license by the first of the year.
3. Back to square one.
You return the bocx license and obtain a license from Panacea
Don't worry about GW, I think the whole bunch has skipped town.
I am familiar with this application as somebody earlier had picked up ont it. I looked it up and as I recall there was a mention of recaf or biocurex, I think In paragraph 204. I sent this to Terry over a month ago and asked if anyone would comment on it and got no reply. I don't get real exited about patent applications.
There has been nothing new out of bocx for over 2-7/2 years that has been verified in writing by an outside source. They presented data that showed it can work at the ISOBM. There was no indication that it could be commercialized. Maybe the test chemicals have a shelf life of 2 days. There has been no indication from abt or bocx that abt is developing a single product based on bocx technology, period. Outside of a general statement by bocx that they are negotiating license agreements with other companies we have seen no indication they have been successful. They stated in the 10q in maybe May 2005 they were seeking other licensee's. Outside of this board nowhere is there a source that says bocx is talking to Siemens. It is all conjecture. I no longer believe there is any substance to this company. I have reduced my position by 55% but will retain the rest just in case I'm wrong, which I have been often. I hope I'm wrong this time.
I'm sick of this dog. I think there is transparency and there is nothing there but promises.
I'm with you. I would settle for any good news even if I knew it wasn't true.
As best I can determine gpro manufactures and markets their own products. Their earnings are 1.51/sh with a market cap of 3.6B. They are not company to be dismissed. Soros has invested a considerable amount in gpro. He may be a jerk but he has agood track record of making money. I don't know how we can pressure bocx management but they need to move foward. I don't want be hearing wait til next year 2 or 3 years down the road. I know you don't agree with what I say but that's ok.
He has a national show that is widely watched. Why can't bocx get on his show or one similar. He does have a way of high lighting his successes and glossing over his failures. But don't we all.
For those that did not see Cramer yesterday, he had the pres of GPRO on his program(www.madmoneyrecap.com second segment). Gpro has developed a blood test for prostate cancer that is almost twice as reliable as PSA. He reported results similat what bocx reports for recaf. They are in clinical trials. If they beat abt to the market abt will not beable to regain their market share using recaf. If bocx doesn't do something now they will go the way of many companies with good ideas but no clue how to commercially produce it or market it. I blame GW for this and Dr. Moro for associating himself with this guy.
If anyone watched Cramer yesterday you saw the interview with the pres of GPRO. You can find it at www.madmoneyrecap.com second segment. Long story mad short, they have a blood test to compete with PSA and it about twice as reliable as PSA. Similar to the reults reported by bocx. GPRO is beginning clinical trials. If they beat abt to market with this test abt will have a hard time replacing it with a similar test if doctors are satisfied with the gpro results. Assuming bocx has a product that is marketable, if they don't do something now they will be a company that had promising research but could do nothing with it. Most of bocx's troubles can be laid at the feet of GW and Dr. Moro for associating with him.
Let GS put in a sell order at market and see where we end up. We'd be back in the twenties. Most anyone on this board that chose to just get out would collapse the price. We are in a hole and it is going to be tough get out. If we get out.
Good storm or bad storm?
One more thing.
If what we belive is true why doesn't abt or someother pharm make a public offer to by 30M shares at say $1.5 and go up from there?
Consider the following statements are true:
1. abt has spent considerable money adapting recaf to their equipment
2. It will cost considerable additional money to conduct the required studies to get fda approval
3. Assuming fda approval it will cost considerable money to train their sales staff to sell the test to doctors and labs.
4. They(abt)are aware of bocx's work on a point of care test
5. This "poc" test is not part of their (abt) license
6. The "poc" test could make abt's test obsolete
Why would abt spend another dime to bring their recaf test to market? Help me here. I want to believe abt will proceed.
I have not spoken with him, I have only communicated via email.
What nobody wants to admit is, there's a fly in the ointment somewhere. If there were truly any positive news bocx would be telling the world. When I ask the tough questions via email either I get no reply or am told that is privileged information. We all need some straight answers but the only way I know to force the issue is to hire a lawyer. I strongly believe we are intentionlly being misled.
I think the last 2 days has to do with Zolax bailing out. Most all of the people on this board own enough stock to negatively effect the stock price if they put in a market sell.
If anyone has time they should compare the latest quarterly report(Item2) with the May 16,2005 report(Item 2). What has changed in 2-1/2 years. They are almost identical. The May 2005 may be obtained from the news section of the bocx web page. If you read only this you will assume not progress has been made in the 2-1/2 years. Whine, whine, whine.
We're getting killed. I need to whine a little
Is there anything positive in the 10Q. It seems to me they are downplaying the ABT license.
Patience is one thing, sticking our heads in the sand is another. Also, paience is relative depending on how long you've owned the stock. At this point I see no evidence that Abbott, Siemens or anyone else has any commercial plans to devlop bocx products. Somebody, please, show me I'm wrong.
After reading your post I don't know if I feel better or worse. This is a very frustrating situation.
That's because the outlook for the company looks very grim.
Observations
pp-15 of SB2 - over the next 12 months they intend to do what said they would over the last 12 months and the 12 months preceeding that.
The terms of the license agreement and the loan agreement stink. I would get out on the street and beg before I would sign that loan agreement.
With such poor business managers I don't see how this company can survive.
According to "Short Squeeze" the October short interest was 138,000 shares. We now know who was selling short. Were they trying to hold down the price? How can they short a stock they own and I can't?
Boy, what a comfort.
I get discouraged, as I'm sure many of you do. I went back and read a number of pr's. Looking at May 10, 2005, management lists six goals for the next 12 months. I can't see where any of the goals have been obtained except getting off the pinks. It's now been 2-1/2 years and we are still hoping for additional licenses. There's not hundreds of companies out there they could be talking to, actually there are very few. I, for one, am tired of the promises. It's always another year of two. Pretty soon I'll be so old it won't matter. Maybe that's management's strategy.
GW - 2/14/07 - $0.72
RM -2/13/07 & 2/14/07 - $0.72
PR - 2-13-07 "Point of Care" pr.
Prior to pr- $0.62
Resembles a P&D
With how many failed companies has GW been involved, if any.
Since the isobm conference the silence has been deafening. Why does't Dr. Moro or abt speakout? Why doesn't some news agency pickup on bocx and scoop the others. It does not make sense to me that bocx is totally ignored except on this board. The news media is so desperate for something to report that they report on anything, except recaf. All reassurance is appreciated.
If there was any good news, bocx would have made it public the second they knew. With all the stories about cancer markers and no mention of recaf or bocx, I'm beginning to think the bocx technology is obsolete. From what is posted here it appears to me that the abt license is similar to many license agreements. Even though abt may have spent millions investigating recaf, $250,000 over 2-1/2 years is chicken feed to abt. I hope I'm wrong.
Is there any evidence that siemens is interested in bocx? It seems good things are always 6 months, a year, 2 years down the road. I feel like a mule following a carrot on a stick.
My guess is, this being a highly competative business, abt does not want the competition to know anything until they are ready to begin sales. At least as little as possible. In most businesses that rely on sales outside the business, who your salesmen call on is confidential. What would they say, we are working on something that is going to put a lot of you jerks out of business. There is so much money spent on cancer treatment that the competition will put up as many road blocks as possible. A case in point is the doctor in Australia that discovered that stomach ulcers are caused by a bacteria was all but run out of the medical field by the drug companies, who made gazillions selling ulcer treatment drugs. For those that don't know he finally infected himself with the bacteria, checked into a hospial when his case became severe and was dagnosed with severe stomach ulcers. At this point he directed the hospital to treat him with antibiotics and within a few days his ulcers were gone. All I'm trying to say is that the less your competitors know about what you are doing the better.
Short interest is up 1558%